文章基本信息

标题：Cystic Fibrosis - Related Diabetes
本地全文：下载
作者：Marcin Makuch ; Marcelina Makuch
期刊名称：Journal of Education, Health and Sport
电子版ISSN：2391-8306
出版年度：2021
卷号：11
期号：6
页码：42-46
DOI：10.12775/JEHS.2021.11.06.005
语种：English
出版社：Kazimierz Wielki University
摘要：<p class="16" style="text-align: justify; line-height: 114%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;" align="justify"><span style="font-family: 'Times New Roman'; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Cystic fibrosis (CF) is life-shortening autosomal recessive disease, caused by mutations in the cystic fibrosis transmembrane conductance regulator protein. The most common of CF complications is cystic fibrosis-related diabetes (CFRD). The pathophysiology of CFRD is complex. The best test for screening and diagnosis of CFRD is the oral glucose tolerance test (OGTT). Insulin therapy is a treatment of choice in CFDR pharmacotherapy. An inseparable element of CFRD therapy is also physical activity and diet.